Evidence map›Paper›PMID 27133778›Full record

ReviewSeminars in fetal & neonatal medicine2016

Microbial therapeutic interventions.

Nicole G Grady, Elaine O Petrof, Erika C Claud

Abstract readReview
In one paragraph

Review in Seminars in fetal & neonatal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicole G GradyUniversity of Chicago, Chicago, IL, USA.
Elaine O PetrofQueen's University, Department of Medicine, Kingston General Hospital, Kingston, ON, Canada.
Erika C ClaudUniversity of Chicago, Chicago, IL, USA. Electronic address: eclaud@peds.bsd.uchicago.edu.

Funding

Preterm infant susceptibility to NEC due to early intestinal microbiome functionR01HD083481 · NICHD · UNIVERSITY OF CHICAGO · PI CLAUD, ERIKA C · 2015 to 2019
$2.5M
NICHD NIH HHS R01 HD083481
6 · The paper itself

Abstract

The microbiome comprises all the microbes living in and on the human body. Human cells are greatly outnumbered by bacterial cells; thus human health depends on the health of the microbial ecosystem. For the immature preterm infant, the microbiome also influences intestinal and immune system development. This has implications for short term morbidities such as neonatal necrotizing enterocolitis and sepsis, but also long term health outcomes. Optimization of the preterm infant microbiome is a growing topic of interest. The microbial world is not one of good versus evil, but rather one of community; thus optimization includes not only minimizing pathogens, but also enhancing beneficial organisms. Options for optimization include judicious antibiotic use, administration of supplements such as prebiotics or probiotics, and transfaunation procedures such as fecal microbial transplant or microbial ecosystem therapeutics. Potential for benefit as well as risk for each of these options will be discussed.

Indexed as

Dietary SupplementsFecal Microbiota TransplantationMicrobiotaPrebioticsProbioticsHumansPrebioticsFecal microbial transplantMicrobial ecosystem therapeuticsMicrobiomePrebioticsProbiotics

Identifiers

PMID27133778
PMCPMC5079850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.